utilized to prescreen samples prior to more conventional viis characterized by end-on attachment of spirochetes to the apical cell membrane of cecal enterocytes to form a dense layer of bacteria aligned parallel to each other and perpendicular to the mucosal surface. 22 Clinical signs associated with cecal spirochetosis in chickens include a reduced growth rate, diarrhea, wet feces on feathers around the vent, feces stained eggs, delayed onset of egg production in pullets, and reduced egg production in laying hens. 1, 5, 18, 22 Spirochetes isolated from hens with diarrhea have been orally administered to specific-pathogen-free chickens, resulting in watery feces and slight retardation of growth. 1, 19 Epidemiologic studies from The Netherlands and Western Australia have shown that the prevalence of intestinal spirochetes in layer and broiler breeder flocks experiencing diarrhea or reduced egg production is significantly greater than their prevalence in clinically normal flocks. 4, 9 Necrotizing typhlocolitis in juvenile common rheas (Rhea americana) from Ohio farms and a zoo was initially described in 1992. 15 Affected birds in 3 flocks experienced de- pression, lethargy, anorexia, loose stools, and 25-80% mortality. Spirochetes characterized by strong ␤-hemolysis were isolated from the ceca. Sequence analysis of 16S ribosomal RNA showed that spirochetes from this outbreak and those later isolated from sick rheas in Iowa are strains of S. hyodysenteriae, the etiologic agent of swine dysentery. 7 A retrospective review of rhea submissions to the California Veterinary Diagnostic Laboratory System from 1990 to 1993 revealed that 41% (13 of 31) of rhea chicks submitted between 6 and 52 weeks of age had necrotizing typhlocolitis. 6 Antimicrobial agents are used for prevention and treatment of bacterial diseases of poultry when therapy is likely to be cost effective. 21 Under ideal circumstances, selection of an appropriate antimicrobial agent begins with isolation and identification of the causative bacteria and determining the minimal inhibitory concentration (MIC) for a panel of potential therapeutic drugs. 14 Descriptions of antibiotic susceptibility patterns of intestinal spirochetes from chickens or rheas have not been published. This study was undertaken to determine MICs for 11 antibacterial compounds against 4 spirochetes isolated from the ceca of chickens and 4 spirochetes cultured from the lower intestinal tract of rheas. The MIC method chosen was agar dilution, which has been widely used for susceptibility testing of Serpulina sp. 2, 8, 12, 13 Spirochetes used in this study were originally cultured from the ceca of chickens or rheas submitted to the veterinary diagnostic laboratories at Iowa State University, Ames (isolates Ia42167, Ia308, Ia35829), Ohio State University, Columbus (isolates OhC-1, OhC-2, OhR-1, OhR303), and the University of Nebraska, Lincoln (isolate Ne12551). Ia42167 and Ia308 have been identified as S. pilosicoli on the basis of multilocus enzyme electrophoresis. 10 OhC-1 and OhC-2 belong to a new species of avian intestinal spirochetes recently named S. alvinipulli. 10, 17 Ia35829, OhR-1, and OhR303 from rheas are strains of S. hyodysenteriae. 7 The remaining rhea isolate, Ne12551, has not been genetically identified.
Antibacterial agents included in this study are commonly available to commercial poultry producers or have been successfully used to treat intestinal spirochete infections of swine. The following antimicrobial agents were tested at serial dilutions ranging from 0.0005 to 200 g/ml: lincomycin, carbadox, tiamulin, bacitracin, chlortetracycline, oxytetracycline, erythromycin, neomycin, and tylosin. Penicillin and streptomycin were tested at serial dilutions ranging from 7.5 to 17,000 IU/ml. Previously established MICs of lincomycin, carbadox, and tiamulin for treatment of infections by S. hyodysenteriae and S. pilosicoli in swine are listed in Table  1 . 2, 11 Antimicrobial compounds in phosphate-buffered saline (PBS) stock solutions were diluted to desired concentrations first in PBS and then in molten trypticase soy bovine blood agar (TSBBA) 24 hours prior to the test. PBS without an antimicrobial agent was used as a growth control. Plates were solidified, stored overnight at 4 C, and dried to eliminate surface moisture immediately before use. Spirochete isolates were streaked on TSBBA plates 96 hours prior to the test and incubated anaerobically at 42 C. Approximately 0.2-0.3 ml of hemolyzed agar was suspended in a 3-ml trypticase soy broth/bead tube and vortexed to render agar chunks into a slurry. Inocula prepared in this manner ranged from 3 ϫ 10 7 to 1 ϫ 10 8 colony-forming units/ml per ml. Drops (10 l) of each diluted isolate were applied in a replicate pattern to antimicrobial MIC plates, each of which contained a different level of antimicrobial agent within the agar.
Inoculated plates were inverted, placed in anaerobic jars at 42 C, and incubated for 96 hours. The MIC was the lowest antimicrobial concentration (highest dilution) that prevented growth. Each MIC represents the median value of 5 tests, with each test conducted in duplicate.
All chicken spirochetes, consisting of 2 S. pilosicoli isolates and 2 S. alvinipulli isolates, were highly susceptible to lincomycin, carbadox, and tiamulin according to criteria established for swine S. pilosicoli ( Table 2 ). MICs were highly variable for chlortetracycline, oxytetracycline, tylosin, bacitracin, erythromycin, neomycin, and penicillin, suggesting that these compounds may be effective against some isolates but not against others. The MIC for streptomycin was consistently high, and this antimicrobial agent probably would not be effective against any of the spirochetes isolated from chickens. Antibiograms for Ia42167 and Ia308 were identical except for neomycin and oxytetracycline. OhC-1 and OhC-2 had the same sensitivity to 7 of 11 compounds tested. With the exception of carbadox and streptomycin, higher antimicrobial concentrations were required to inhibit strains of S. pilosicoli from Iowa. Differences in antimicrobial susceptibility patterns observed between S. pilosicoli and S. alvinipulli from Ohio may be due to dissimilar genetics or to development of resistance by S. pilosicoli following previous exposure to antimicrobial agents in the field.
All rhea spirochetes, consisting of 3 S. hyodysenteriae isolates and 1 unidentified spirochete, were susceptible to lincomycin, carbadox, and tiamulin if MICs determined for swine S. hyodysenteriae are used as the standard (Table 3) . Chlortetracycline and tylosin had variable MICs. The MICs for all remaining antimicrobial agents in this study were identical for all 4 of the rhea isolates. MICs for oxytetracycline, neomycin, and penicillin tended to be higher for rhea than for chicken isolates. Each of the 4 rhea isolates had identical MICs for 8 of the 11 antimicrobial agents tested, which may reflect similar genetic patterns.
Lincomycin is approved for use in broiler chickens and probably represents the drug of choice for treatment of intestinal infections caused by Serpulina sp. in chickens and rheas. Carbadox and tiamulin are approved for treatment of swine dysentery but have not been cleared by the Food and Drug Administration's Center for Veterinary Medicine for use in poultry.
